BioNTech SE (BNTX)
108.23
+6.09
(+5.96%)
USD |
NASDAQ |
Nov 21, 16:00
108.77
+0.54
(+0.50%)
After-Hours: 20:00
BioNTech Profit Margin (Quarterly): 15.91% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 15.91% |
| June 30, 2024 | -627.7% |
| March 31, 2024 | -168.0% |
| December 31, 2023 | 30.96% |
| September 30, 2023 | 17.94% |
| June 30, 2023 | -113.5% |
| March 31, 2023 | 39.33% |
| December 31, 2022 | 53.26% |
| September 30, 2022 | 51.57% |
| June 30, 2022 | 52.31% |
| March 31, 2022 | 58.02% |
| December 31, 2021 | 57.23% |
| September 30, 2021 | 52.75% |
| Date | Value |
|---|---|
| June 30, 2021 | 52.50% |
| March 31, 2021 | 55.07% |
| December 31, 2020 | |
| September 30, 2020 | -311.1% |
| June 30, 2020 | -211.8% |
| March 31, 2020 | -192.8% |
| December 31, 2019 | -208.1% |
| September 30, 2019 | -105.0% |
| June 30, 2019 | -194.2% |
| March 31, 2019 | -155.4% |
| December 31, 2018 | -2.12% |
| September 30, 2018 | -114.9% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-627.7%
Minimum
Jun 2024
58.02%
Maximum
Mar 2022
-68.21%
Average
30.96%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| Novavax Inc | -143.5% |
| DBV Technologies SA | -- |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals PLC | -- |
| NuCana PLC | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -2.35% |
| Return on Assets | -2.06% |
| Return on Invested Capital | -2.32% |
| Gross Profit Margin (Quarterly) | 85.63% |
| Operating Margin (Quarterly) | 0.84% |
| Return on Net Operating Assets | -10.80% |